Skip to main content
Find more clinical trials

Caregiver Stress: Interventions to Promote Health and Well-being

Start: January 2010
End: May 2014
Enrollment: 384

What Is This Study About?

Investigators will test psycho-education and physical exercise, individually and in combination, as ways to promote physical health (especially reduction in cardiovascular risk) and emotional well-being in family caregivers of people with chronic illness. Two groups of family caregivers will participate, those who care for African American dementia patients and those who care for heart failure patients. Researchers hypothesize that caregivers who receive the combined psycho-education and physical exercise intervention will have better psychological functioning, behavioral outcomes, cardiovascular risk measures, neuroendocrine function, and overall health outcomes compared to caregivers who receive only one intervention.

Do I Qualify To Participate in This Study?

Minimum Age: 21 Years

Must have:

++Family caregiver, defined as a spouse, partner, or other adult family member living in the same house or in contact with patient in a caregiver relationship at least 4 times per week for at least 1 hour or more++English fluency++Ambulatory and physically able to engage in a structured low-impact walking and upper-body strength training program++Self-identify as African American for the Alzheimer's disease study

Must NOT have:

++Nonsedentary, defined as engaging in more than 30 minutes of moderately strenuous exercise three times or more per week

++Medical or physical condition that precludes participation in the exercise component of the study (e.g., severe arthritis or mobility problems, uncontrolled hypertension or diabetes, renal insufficiency, or history of angina with activity)++Current psychiatric comorbidity (alcohol or drug abuse/dependence, bipolar or psychotic disorder, suicidal ideation)

++Current smoker++Cognitive problems++Ischemic changes or inappropriate blood pressure changes on treadmill tes

t++Acute inflammation at start of study or follow-up testing++Prohibited medications: corticosteroids

 
Study Contact
Mary Laszlo

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Georgia
Emory Universtiy
Atlanta, GA 30322

Who Sponsors This Study?

Lead: Emory University

Collaborator Sponsor

  • National Institute of Nursing Research (NINR)

Source: ClinicalTrials.gov ID: NCT01188070